These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Screening for the early diagnosis of prostatic carcinoma in Ossola: results after 1 year of effort]. Pagani G; Iannicelli P; Rosa A; Aimè G; Ceratti G; Cobianchi PG Arch Ital Urol Androl; 1994 Feb; 66(1):47-50. PubMed ID: 7516781 [TBL] [Abstract][Full Text] [Related]
26. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database. King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935 [TBL] [Abstract][Full Text] [Related]
27. A Cost-Utility Analysis of Prostate Cancer Screening in Australia. Keller A; Gericke C; Whitty JA; Yaxley J; Kua B; Coughlin G; Gianduzzo T Appl Health Econ Health Policy; 2017 Feb; 15(1):95-111. PubMed ID: 27757918 [TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer. Shteynshlyuger A; Andriole GL J Urol; 2011 Mar; 185(3):828-32. PubMed ID: 21239021 [TBL] [Abstract][Full Text] [Related]
29. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis. Tawfik A Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237 [TBL] [Abstract][Full Text] [Related]
30. Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies. Roth JA; Gulati R; Gore JL; Cooperberg MR; Etzioni R JAMA Oncol; 2016 Jul; 2(7):890-8. PubMed ID: 27010943 [TBL] [Abstract][Full Text] [Related]
31. The National Cancer Institute Multi-Screening Trial. Prorok P Can J Oncol; 1994 Nov; 4 Suppl 1():98-9; discussion 100-1. PubMed ID: 8853500 [No Abstract] [Full Text] [Related]
33. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Raj GV; Partin AW; Polascik TJ Cancer; 2002 Feb; 94(4):987-96. PubMed ID: 11920467 [TBL] [Abstract][Full Text] [Related]
34. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States. Prasad SM; Gu X; Lipsitz SR; Nguyen PL; Hu JC Cancer; 2012 Mar; 118(5):1260-7. PubMed ID: 21823112 [TBL] [Abstract][Full Text] [Related]
35. An audit of follow-up chest radiography after coronary artery bypass graft. Karthik S; O'Regan DJ Clin Radiol; 2006 Jul; 61(7):616-8. PubMed ID: 16784948 [TBL] [Abstract][Full Text] [Related]
36. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Zeliadt SB; Etzioni R; Ramsey SD; Penson DF; Potosky AL Med Care; 2007 Feb; 45(2):154-9. PubMed ID: 17224778 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology and screening for prostate cancer. Moul JW Am J Manag Care; 1997 Aug; 3(8):1200-5; quiz 1208, 1210. PubMed ID: 10170302 [TBL] [Abstract][Full Text] [Related]
38. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983 [TBL] [Abstract][Full Text] [Related]